Scientific Committee Members of Targeting Phage Therapy 2026
Sandra Sevilla, President, CECAV, Spain.
Ms. Barbara Brenner, Kanzlei BRENNER, Germany
Prof. Domenico Frezza, University of Roma Tor Vergata, Italy
Prof. Robert Schooley, University of California, USA
Dr. Mariagrazia Di Luca, University of Pisa, Italy
Prof. Marvin Edeas, INSERM – Institut Cochin, Université de Paris, France
Dr. Ekaterina Chernevskaya, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Russia
Dr. Nannan Wu, Shanghai Public Health Clinical Center, China
Dr. Jumpei Fujiki, Rakuno Gakuen University, Japan
Scientific Committee Members of Targeting Phage Therapy
 |
Ms. Barbara Brenner, Kanzlei BRENNER, Germany |
 |
Prof. Domenico Frezza, University of Roma Tor Vergata, Italy |
 |
Prof. Robert Schooley, University of California, USA |
 |
Dr. Mariagrazia Di Luca, |
 |
Prof. Marvin Edeas, |
 |
Dr. Ekaterina Chernevskaya, |
 |
Dr. Anna Pistocchi, Università degli Studi di Milano, Italy |
 |
Dr. Brieuc Van Nieuwenhuyse, |
 |
Dr. Nannan Wu, |
 |
Dr. Atonia P. Sagona, |
 |
Dr. Jumpei Fujiki |
|
Scientific Committee Members of Phage Therapy 2025
 |
Ms. Barbara Brenner, Kanzlei BRENNER, Germany |
|
Prof. Domenico Frezza, University of Roma Tor Vergata, Italy |
|
Prof. Robert Schooley, University of California, USA |
|
Dr. Mariagrazia Di Luca, University of Pisa, Italy |
|
Prof. Marvin Edeas, INSERM – Institut Cochin, Université de Paris, France |
 |
Dr. Ekaterina Chernevskaya, |
|
Dr. Anna Pistocchi, Università degli Studi di Milano, Italy |
|
Dr. Brieuc Van Nieuwenhuyse, UCLouvain, Belgium |
|
Dr. Atonia P. Sagona, University of Warwick, United Kingdom |
|
Dr. Nannan Wu, Shanghai Public Health Clinical Center, China |
|
Dr. Jumpei Fujiki Rakuno Gakuen University, Japan |